Editor’s note: The attached comment letter was submitted to the Centers for Medicare &
Medicaid Services on Dec. 23, 2024.
Schaeffer Senior Scholar Dima Qato submitted comments to CMS in response to a request for comment on a proposed rule expanding coverage of contraception without cost sharing. Qato makes the following points:
- Removing prescribing requirements and cost barriers could significantly improve access to contraception.
- Pharmacies must have information about reimbursement or clear guidance. Otherwise, implementation may not be equitable across state and neighborhoods.
- CMS should work with state-level regulators to develop and enforce dispensing and inventory mandates to ensure adequate stocking of OTC contraceptives.
Read the comment letter here.Â
Sign up for Schaeffer Center news